INTRODUCTION {#S5}
============

Premature infants have an immature gastrointestinal tract, with a gut epithelium that has diminished barrier function and increased permeability. This allows for translocation of bacteria from the gut to the bloodstream, leading to systemic inflammation or sepsis ([@R1]--[@R6]). In premature infants it has been hypothesized that antibiotic use, coupled with the infants' underdeveloped immune systems and gut epithelia, promotes intestinal bacterial communities that are less diverse and enriched with potential pathogens ([@R7]--[@R11]). Prematurity, lack of diversity in the gut bacterial communities, and the presence of pathogenic bacteria have also been associated with systemic inflammation and the development of sepsis as well as necrotizing enterocolitis, all of which are important complications of prematurity ([@R8],[@R12],[@R13]). The bacteria that premature intestinal tracts lack include taxa frequently found to colonize the gut of healthy term infants, as well as bacteria that are associated with immune training, metabolic function, and ultimately decreased risk of lifelong health issues such as obesity and allergy ([@R11],[@R14]--[@R16]).

The factors responsible for the altered colonization patterns observed in premature infants compared to their healthy term counterparts are not well-defined. Physiological differences in the premature gut epithelium likely fosters abnormal colonization patterns from birth. Premature infants' exposure to antibiotics before, during, and after birth, likely further contributes to aberrant gut bacterial colonization. Understanding how infant gut bacterial communities vary by gestational age at birth and how they are shaped by exposures can help inform future treatment in the hopes of decreasing pathogen colonization and increasing abundance of beneficial bacteria.

In this study, we aimed to evaluate how gut bacterial community structure varies across the spectrum of gestational age at birth and to assess the effects of various exposures, such as newborn antibiotic administration, delivery mode, and breastmilk feeding, on the gut microbiota of preterm infants.

METHODS {#S6}
=======

Ethical Approval {#S7}
----------------

Institutional review board approval was obtained from the Committee for the Protection of Human Subjects at Dartmouth College with yearly renewal. Parents provided written, informed consent.

Subject Cohorts and Inclusion Criteria {#S8}
--------------------------------------

We studied 17 premature infants hospitalized in a New Hampshire neonatal intensive care unit (NICU) and an additional 13 premature infants enrolled in the New Hampshire Birth Cohort Study (NHBCS) ([Table 1](#T1){ref-type="table"}). We compared these with 176 term infants also enrolled in the NHBCS. Inclusion criteria for the cohort of infants hospitalized in the NICU were appropriate size for gestational age (AGA) and ≤ 14 days of age at the time of enrollment. We excluded infants with major anomalies, such as trisomies, other genetic syndromes, and clinical syndromes. Major birth defects such as gastroschisis, complex congenital heart disease, or renal anomalies were excluded. Infants had a length of stay in the NICU between 29 and 174 days. 3 infants in the NICU had sepsis, none had necrotizing enterocolitis, and 5 had bronchopulmonary dysplasia. A subset of these infants have been previously studied ([@R17],[@R18]). The NHBCS is a prospective longitudinal large epidemiological cohort study of pregnant women and their children ([@R19],[@R20]). Pregnant women aged 18--45 in New Hampshire are enrolled at approximately 24 to 28 weeks of gestation. Inclusion criteria for mothers include having a singleton pregnancy, a private drinking well at home, and no plans to move. We included infants with no noted congenital abnormality. Gut microbiome data on a large proportion of these infants has been previously described ([@R21]).

Infant Exposures {#S9}
----------------

Data was collected on the following exposures: newborn antibiotic exposure (antibiotics given during the first days after birth while in hospital), delivery mode (vaginal delivery or Caesarean section), and breastmilk exposure (still consuming breastmilk at time of sample collection) ([Table 2](#T2){ref-type="table"}). Antibiotic administration data was abstracted from the infant's hospital medical record. For infants hospitalized in the NICU, delivery and breastmilk feeding information was also abstracted from the medical record; for NHBCS subjects, these exposures were ascertained by telephone follow-up questionnaires with mothers. Additional exposure data was collected for the premature infants in the NICU, such as antibiotic exposure on day of sample collection and exclusive breastmilk feeding at time of sample collection ([Table 3](#T3){ref-type="table"}).

Sample Collection {#S10}
-----------------

In the NICU cohort, stool samples were collected weekly beginning with first meconium and ending with hospital discharge. Samples were collected from diapers using sterile wooden depressors, transferred to sterile tubes, and aliquoted and stored at −80°C. In the NHBCS, stool samples were collected at two time points: at time of first stool after passing of meconium ("transitional" stool, 0--3 days of life) and at 6 weeks. Most NHBCS infants contributed samples at only one of these 2 time points. Premature infants from NHBCS born at \<36 weeks gestation only contributed 6-week stool, so it was unlikely that they were hospitalized at time of sample collection. Stool was immediately frozen at home at −20°C after collection. Then stool samples were delivered in cold pack, thawed to 4°C, aliquoted in sterile tubes, and suspended in RNAlater. After 24 hours in RNAlater in refrigerator, samples were moved to −80°C long term storage.

Sample processing {#S11}
-----------------

For the samples from the preterm infants in the NICU, DNA extraction was performed after thawing of samples using the MoBio Powersoil bacterial DNA isolation kit (MoBio, Carlsbad, California), as previously described ([@R18]). DNA was extracted from thawed NHBCS stool samples using Zymo Research's ZR fecal DNA MiniPrep Kit, also described previously ([@R21]). Both kits include a bead-beating step. The MoBio kit used 0.7 mm garnet beads, while the Zymo kit used 0.5 mm high density ceramic beads.

Sample Sequencing and Data Analysis {#S12}
-----------------------------------

Sequencing of the V4--V5 hypervariable region of 16S ribosomal DNA was performed using the Illumina MiSeq platform. Details of sequencing methods, taxonomic assignment, and data analysis are described in [Supplemental Methods](#SD1){ref-type="supplementary-material"}.

RESULTS {#S13}
=======

Sequencing {#S14}
----------

After excluding 25 samples due to low read counts, 78 samples from 30 premature infants and 189 samples from 176 term infants were evaluated. The range of gestational ages for infants in each group is shown in [Table 1](#T1){ref-type="table"}. Sequencing of these samples resulted in a total of 22,012,483 reads for the 267 (mean: 82443.76, range: 14,002--1,072,107). The dominant bacteria identified in premature infant stool samples was *Enterobacteriaceae*, making up 32% of normalized reads, followed by the genera *Clostridium* (10%), *Enterococcus* (10%), and *Veillonella* (9%) ([Figure 1a](#F1){ref-type="fig"}). In term infants, bacterial genera from the family *Enterobacteriaceae* were also the most common, making up 20% of all normalized reads, followed by *Bacteroides* (19%), *Bifidobacterium* (15%), and *Streptococcus* (9%) ([Figure 1a](#F1){ref-type="fig"})*. Bacteroides*, *Bifidobacterium,* and *Streptococcus* made up only 7%, 3% and 2% of total normalized reads among premature infants, respectively ([Figure 1a](#F1){ref-type="fig"}).

Bacterial Alpha-Diversity and Abundance Differences Between Premature and Term Infants {#S15}
--------------------------------------------------------------------------------------

Bacterial alpha-diversity, which was measured by Simpson's Diversity Index (SDI), varied throughout the 6 weeks of life for individual premature infants with longitudinal stool samples ([Figure 1b](#F1){ref-type="fig"}). After adjusting for the effects of exposures, including delivery mode, newborn antibiotics, and breastmilk exposure at time of sample collection, there was not a significant difference in the change in bacterial alpha-diversity between term and premature infants over time (p=0.054, [Figure 1b](#F1){ref-type="fig"}). Across all time-points, bacterial alpha-diversity was not statistically significantly different between term and premature infants after adjusting for exposures (p=0.700, [Figure 1c](#F1){ref-type="fig"}).

Differences in bacterial abundance between premature and term infants were also assessed. After adjusting for exposures in addition to age at time of stool sample collection, there were no statistically significant differences in bacterial abundance between premature and term infants.

Hierarchical Clustering {#S16}
-----------------------

Hierarchical clustering analysis revealed that premature infant samples clustered separately from term infant samples, however, the clustering was not statistically significant (p=1 for the cluster containing mostly premature infant samples, [Figure 2a](#F2){ref-type="fig"}). Moderate and late preterm infant samples (32 weeks to \<37 weeks) interspersed between the extremely (\<28 weeks) and very preterm (\<32 weeks) and term samples ([Figure 2a](#F2){ref-type="fig"}).

Bacterial Alpha-Diversity and Abundance Differences at 6 weeks {#S17}
--------------------------------------------------------------

At approximately 6 weeks of age, the difference in bacterial alpha-diversity, after accounting for exposures, was statistically significant (p=0.027), with premature infants having lower bacterial alpha-diversity than term infants at 6 weeks ([Figure 2b](#F2){ref-type="fig"}). However, there were no statistically significant differences in bacterial abundance in premature infants compared to term infants at 6 weeks of age.

Bacterial Phylogenetic Relatedness Differences Between Premature and Term Infants {#S18}
---------------------------------------------------------------------------------

Bacterial phylogenetic relatedness differences between premature and term infants were evaluated at the 6-week time point to address the more mature, established microbiome in both groups. After adjusting for exposures (but not repeated measures, see *Methods*), the difference in phylogenetic relatedness between the two groups of infants was not significant (p=0.557, [Figure 3a](#F3){ref-type="fig"}).

Differences Among Premature Infants by Gestational Age at Birth {#S19}
---------------------------------------------------------------

To test the hypothesis that gut bacterial community structure varied with degree of gestational immaturity at birth, we divided the premature infants into 3 groups: extremely premature infants (gestational age at birth \<28 weeks), very premature infants (28≤ GA \<32 weeks), and moderate-late premature infants (GA ≥32 weeks). We observed differences in bacterial alpha-diversity between extremely premature and moderate-late premature, and between extremely and very premature infants after adjusting for age and exposures (p=0.004 and p=0.011, respectively, [Figure 3b](#F3){ref-type="fig"}). We did not find differences in bacterial alpha-diversity between very and moderate-late premature infants after accounting for exposures and age (p=0.697, [Figure 3b](#F3){ref-type="fig"}). There were differences in bacterial phylogenetic relatedness at 6 weeks of age between extremely and very premature infants (p=0.033) after adjusting for exposures but not between very and moderate-late premature infants (p=0.138) or extremely and moderate-late premature infants (p=0.160).

Earlier Gestational Age at Birth Compared to Later Gestational Age at Birth {#S20}
---------------------------------------------------------------------------

Given the clustering of many moderate-late premature samples with term samples, we divided the infants into two groups: those who had an earlier gestational age at birth (GA \<32 weeks) and those who had a later gestational age (GA ≥32 weeks). Infants born at a later gestational age had greater abundance of *Streptococcus* and *Bifidobacterium* (p≪0.001, p=0.001, respectively, [Figure 3c](#F3){ref-type="fig"}). At 6 weeks of age, after adjusting for exposures, infants born \>32 weeks gestation had greater abundance of *Bacteroides*, while earlier GA infants \< 32 weeks had greater abundance of *Parabacteroides* (p≪0.001 and p=0.005, respectively, [Supplemental Figure S1](#SD1){ref-type="supplementary-material"}). Across all time points, bacterial alpha-diversity was greater in later GA infants than in earlier GA infants, even after adjusting for exposures and age (day of life) (p=0.015, [Figure 4a](#F4){ref-type="fig"}). Bacterial alpha-diversity did not, however, change differently over time between earlier and later GA infants (p=0.298). Similarly, at 6 weeks of age, bacterial alpha-diversity, after accounting for exposures, remained distinct between earlier and later GA infants (p=0.014). Bacterial phylogenetic relatedness differences between earlier versus later GA infants at 6 weeks of age, after adjusting for exposures, were marginally statistically significant (p=0.088, [Figure 4b](#F4){ref-type="fig"}).

Additionally, when comparing moderate-late premature infants to term infants, there were no apparent differences in bacterial alpha-diversity after adjusting for exposures and age (p=0.764), though the number of moderate-late premature compared to term samples was small (n=16 compared to n=174 after omitting samples missing exposure data). Bacterial phylogenetic relatedness differences at 6 weeks were not evident between moderate-late and term infants after accounting for exposures (p=0.354). The abundance of *Pantoea* was statistically significantly greater in moderate-late premature infants compared to term infants after adjusting for exposures and age (p=0.034), but there were no other statistically significant differences in bacterial abundance between these two groups of infants. These results indicate that moderate-late premature infants most likely have a community structure that more closely resembles term infants.

Analysis of Corrected Gestational Age in Premature Infants {#S21}
----------------------------------------------------------

Corrected gestational age was defined at gestational age at birth + day of life at time of sample collection. We compared bacterial composition in premature infants born at different gestational ages when they were at similar corrected gestational ages at time of sample collection ([Supplemental Figure S2](#SD1){ref-type="supplementary-material"}). While composition appears roughly different between infants born at different gestational ages, there were no significant differences in bacterial alpha-diversity between these groups of infants after accounting for exposures ([Supplemental Table 1](#SD1){ref-type="supplementary-material"}). Bacterial alpha-diversity does appear to increase as corrected gestational age increases (p=0.003, [Figure 5](#F5){ref-type="fig"}).

Associations with Exposures Among Premature Infants {#S22}
---------------------------------------------------

We identified 3 potential exposures thought to affect premature infant gut microbial structure, which included newborn antibiotic exposure, delivery mode, and breastmilk exposure ([Table 2](#T2){ref-type="table"}). Additionally, we collected additional exposure data from the premature infants in the NICU, such as antibiotic exposure on day of sample collection and exclusive breastmilk feeding at time of sample collection ([Table 3](#T3){ref-type="table"}). Corrected gestational age at time of stool sample collection was also adjusted for. Among the premature infants, none of the three exposures (antibiotics in the first few days of life, a vaginal vs. C-section delivery, or breastmilk exposure) had statistically significant independent effects on bacterial alpha-diversity (p=0.311, p=0.324, p=0.660) after adjustment for corrected gestational age. Earlier gestational age at birth negatively associated with bacterial alpha-diversity, but it was not significant after adjusting for exposures and corrected gestational age (p=0.390). We also evaluated the effects of exposures and corrected gestational age on the abundance of the bacterial genera known to be abundant in term infants, such as *Streptococcus*, *Bifidobacterium*, *Bacteroides*, and *Lactobacillus*. Newborn antibiotic use was associated with lower *Bifidobacterium* and *Bacteroides* abundance (p=0.015 and p=0.041). Vaginal delivery was associated with greater *Bacteroides* abundance (p=0.007), while breastmilk exposure at time of sample collection was associated with a decreased abundance of *Lactobacillus* (p=0.017). Corrected gestational age at time of sample collection was positively associated with greater *Lactobacillus* and *Streptococcus* abundance (p=0.031 and p\<0.001, respectively).

In the premature infant cohort in the NICU, after adjusting for corrected gestational age, no exposure was found to have significant independent effects on bacterial alpha-diversity, though corrected gestational age at time of sample collection had a positive independent effect (p=0.015). Consumption of breastmilk at time of sample collection had marginally significant effects on bacterial phylogenetic relatedness at 6 weeks after adjusting for other exposures and corrected gestational age (p=0.054). Antibiotics and corrected gestational age, but not delivery mode, exclusive breastmilk feeding or any breastmilk consumption at time of sample collection, had significant effects on bacterial abundance of *Streptococcus*, *Bacteroides*, and *Lactobacillus*. Antibiotic use at time of sample collection was associated with greater *Bacteroides* and *Lactobacillus* abundance (p=0.047 and p=0.042). Corrected gestational age at time of sample collection was positively associated with greater *Lactobacillus* and *Streptococcus* abundance (p=0.017 and p=0.021, respectively).

DISCUSSION {#S23}
==========

In our study, we identified differences in gut bacterial composition between premature and term infants in the first 6 weeks of life, using data from a cohort of premature infants in the NICU, as well as premature and term infants enrolled in a large, comprehensive molecular epidemiology study, the NHBCS. We found that dominant taxa differ between premature and term infants; however, there are no statistically significant differences in bacterial alpha-diversity, abundance, and phylogenetic relatedness after adjustment for the effects of exposures such as newborn antibiotic administration, delivery mode, and breastmilk exposure at time of sample collection. We also evaluated the effects of various exposures on the premature infant intestinal microbiota, but also did not find any significant effects on bacterial alpha-diversity or phylogenetic relatedness. We did find significant differences in gut bacterial alpha-diversity between premature infants depending on gestational age at birth, as well as between premature and term infants at 6 weeks of age.

The primary difference between premature and term infants with respect to dominant taxa was the decreased abundance of the genera *Bifidobacterium*, *Bacteroides,* and *Streptococcus.* We also observed decreased abundances of *Bifidobacterium*, *Bacteroides*, and *Streptococcus* in the earlier GA at birth infants compared to those born at a later GA. A paucity of *Bacteroides*, *Bifidobacterium*, *Streptococcus*, and *Lactobacillus* in premature infants have been described previously ([@R14],[@R16]). *Bifidobacterium*, some species of which may help prevent colonization of the infant gut by pathogenic organisms ([@R22]), is not well established in the gut of premature infants born at a gestational age earlier than 33 weeks ([@R15]). In other studies of term, vaginally delivered infants, there is high abundance of *Bacteroides* and *Bifidobacterium* less than a week after birth ([@R23]). *Bifidobacterium* and *Bacteroides* are bacterial genera considered health-promoting and interact directly with the burgeoning immune system in infancy ([@R22],[@R24],[@R25]). *Bacteroides fragilis* has been found to produce a bacterial polysaccharide that aids in the maturation of the immune system and production of regulatory T cells ([@R24]--[@R26]), and in a murine model noted for gut barrier defects, oral treatment with *B. fragilis* reduced gut permeability and altered microbial composition ([@R27]). We did find that early antibiotic use was associated with lower *Bifidobacterium* and *Bacteroides* abundance in premature infants, suggesting that early antibiotic exposure can affect future gut bacterial composition among premature infants. *Streptococcus* is also known to be one of the first colonizers of the gut in term infants ([@R28],[@R29]), and in our study, we found that it was not among the top 10 dominant taxa in premature infants, while it was among the top 4 dominant tax in our term infants. Caesarean-section delivery has been associated with depletion of *Lactobacillus* ([@R30]); however, we did not find that delivery mode was associated with *Lactobacillus* abundance in the premature infants in our study.

We found that after performing hierarchical clustering, extremely and very preterm infants clustered together (GA \<32 weeks), but moderate-late preterm (32≤ GA \<37) infant samples were interspersed among both the extremely and very preterm samples and the term samples. Furthermore, we found significant differences in the premature infant gut microbiota based on gestational age at birth. Extremely premature infants (born before 28 weeks of gestational age) had significantly lower bacterial alpha-diversity compared to very premature (GA ≥28 but \<32 weeks) and moderate-late premature infants (GA ≥32 but \<37 weeks) even after adjusting for exposures. There were also significant differences in bacterial phylogenetic relatedness between the extremely and very premature infants. These results suggest that gestational age at birth has important associations with gut bacterial structure in premature infants, whether it be related to the maturity of the intestinal tract and the bacteria that are able to colonize this intestinal environment, or potentially related to medical treatment and length of stay in a hospital environment.

We compared bacterial alpha-diversity and phylogenetic relatedness between the moderate-late preterm infants and term infants, and found that they did not differ even after accounting for exposures, supporting the finding of moderate-late preterm and term samples clustering together. Comparing the extremely and very preterm infants (GA \<32 weeks) to the moderate-late preterm and term infants (GA ≥32 weeks), differences in bacterial alpha-diversity were identified. In an analysis of premature infants only, earlier gestational age was negatively associated with bacterial alpha-diversity, suggesting that greater gestational immaturity at birth is related to a less diverse gut microbiome. These results all together appear to suggest that infants born between 32 and 37 weeks of gestation have gut bacterial communities in the first 6 weeks of life are more similar to those of term infants than those of infants born before 32 weeks of gestation. This may point to the potential benefit of probiotic supplementation in extremely and very preterm infants, as their gut bacterial communities differ significantly from those of infants with a later gestational age at birth (≥32 weeks). Additionally, these differences in gut bacterial composition between infants born at an earlier versus a later gestational age may reflect differences in environmental exposures between these two groups of infants, as more premature infants were hospitalized, exposed to more antibiotics and other medical interventions, while moderate-late preterm and term infants likely hospitalized for much shorter periods or not hospitalized at all, and were much less likely to have experienced medical interventions.

We did observe an upward trend in bacterial alpha-diversity with increasing corrected gestational age in the premature infants. Though we did not observe significant similarities in bacterial composition among premature infants of different degrees of gestational prematurity at birth when they were at similar corrected gestational ages, there were no significant differences in bacterial alpha-diversity between groups of infants. Corrected gestational age had a significant positive independent effect on bacterial alpha-diversity in premature infants, as well as a positive effect on the abundance of the bacterial genera *Lactobacillus* and *Streptococcus*.

Limitations of this study include a relatively small number of premature infants enrolled compared to the number of term infants, and a much smaller number of longitudinal samples among the term infants compared to premature infants. Study subjects were drawn from a relatively homogeneous northern New England population. While this compromises the generalizability of our findings, it also reduces the sources of variation that could affect our observations. Also, two different DNA extraction kits were used, each for a different cohort, potentially confounding results comparing premature and term infants, and earlier GA at birth vs. later GA infants. Few studies have been published comparing the MoBio and Zymo DNA extraction methods, but one study suggests that representation of bacterial genera in samples does not significantly differ across these DNA extraction methods, though this study looked at plaque and saliva samples ([@R31]). A research report comparing our two kits showed that significantly different microbiomes were not produced if tested from the same intestinal sample, suggesting that the two kits give comparable results ([@R32]).

Our analysis of the effects of diet on the premature gut microbiome was limited since all of our premature infants had exposure to breastmilk at some point. However, recent research involving the NHBCS cohort suggests that infants fed both breastmilk and formula more closely resemble infants that are exclusively formula fed than infants that are exclusively breastmilk fed ([@R21]). Thus, while most of our premature infants were consuming breastmilk at time of stool sample collection, they were also often receiving human milk fortifier or formula. We were, however, able to identify a number of samples where the premature infants had only been exposed to breastmilk. Additionally, our premature infants in the NICU were often fed donor breastmilk when maternal breastmilk was not available. Donor breastmilk is pasteurized, which may have affected gut colonization patterns as breastmilk contains commensal bacteria ([@R33]). Finally, in the bacterial phylogenetic relatedness analyses, we had to assume that each sample was independent, which may have biased results since not all infants donated the same number of samples.

CONCLUSION {#S24}
==========

In our study of premature and term infants, we found that premature infants had lower abundance of a number of keystone bacterial genera found in healthy term infants, many of which are considered immune training and health-promoting. We found an association between early antibiotic use and lower *Bifidobacterium* and *Bacteroides* abundance in our premature infants, pointing to the effect of early antibiotic exposure on future gut bacterial composition. We also found significant differences in bacterial alpha-diversity between premature infants based on gestational age at birth, with lower bacterial alpha-diversity seen in infants with an earlier gestational age at birth. When we compared infants born at an earlier gestational age (GA \<32 weeks) compared to infants born at a later gestational age (GA ≥32 weeks), we found differences in bacterial alpha-diversity (both at 6 weeks of age and across all time points). Bacterial alpha-diversity trended up with increased corrected gestational age. Our results suggest that premature infants with a later gestational age at birth resemble term infants, and that interventions to alter the gut microbiota may be of greatest value in extremely and very preterm infants.
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![Top 10 most abundant taxa (a) and bacterial alpha-diversity differences between premature and term infants (b, c)\
(a) Bar charts depicting the percentage of normalized reads that a bacterial taxon makes up in the stool of premature infants and term infants. The top 10 most dominant taxa are depicted. (b, c) Bacterial alpha-diversity differences (b) over time and (c) across all time points. The bacterial alpha-diversity (SDI) of stool samples from premature and term infants is indicated on the y-axis. P-value is adjusted for exposures (newborn antibiotics, delivery mode, and breastmilk feeding at time of sample collection) and age (day of life). (b) Straight lines were fitted to the bacterial alpha-diversity data, and indicate the change in stool bacterial alpha-diversity over time (slope) in premature infants (red) and term infants (blue). The p-value represents the significance of the difference in slopes, and is adjusted for exposures. On the x-axis is the day of life at which a stool sample was collected. (c) Box-plots showing bacterial alpha-diversity differences between premature and term infants across all time points.](nihms964261f1){#F1}

![Hierarchical clustering of stool samples of term and premature infants (a), and bacterial alpha-diversity differences at 6 weeks of age (b)\
(a) Below the dendrogram are bars depicting which samples belong generally to premature (black) or term infants (gray), as well as which samples belong to extremely preterm infants (green), very preterm (blue), or moderate-late preterm infants (red). (b) The bacterial alpha-diversity (SDI) of stool samples from premature and term infants is indicated on the y-axis. P-value is adjusted for exposures.](nihms964261f2){#F2}

![Bacterial phylogenetic relatedness differences between term and premature infants at 6 weeks of age (a), and bacterial alpha-diversity differences based on gestational maturity (b) and bacterial abundance differences between infants born at an earlier or later gestational age (c)\
(a) Principal Coordinates Analysis plot showing bacterial phylogenetic relatedness differences between 6-week stool samples from premature (red) and term infants (blue). P-value is adjusted for exposures. PC1 = principal coordinate 1, PC2 = principal coordinate 2. Percentage refers to percentage of variance explained by the principal coordinate. (b) The bacterial alpha-diversity (SDI) of infant stool samples is indicated on the y-axis. P-value is adjusted for exposures and age (day of life). Infants are divided into groups based on gestational age at birth. Term is infants born at ≥37 weeks of gestation, moderate-late (Mod-Late) preterm infants are born at ≥32 weeks of gestation but \<37 weeks, very preterm infants are born between 28 and \<32 weeks of gestation, and extremely preterm infants are born between 24 and \<28 weeks of gestation. Number of stool samples for each group is noted. However, exposure data for infants was occasionally not available, so number of samples evaluated for the adjusted analyses may be lower. (c) Bacterial taxa were evaluated for differences in abundance between infants born at a later compared to earlier gestational age at birth after with adjustment for exposures and age (day of life). On the x-axis, an abundance difference of greater than zero indicates that the bacterial taxon is found in greater abundance in infants born at a later gestational age (GA ≥32 weeks), while an abundance difference of less than zero indicates that the taxa is found in greater abundance in infants born at an earlier gestational age (GA \<32 weeks). On the y-axis is the −log~10~ of the p-value for the abundance difference. A greater −log~10~ of the p-value indicates a more significant p-value. Red circles indicate taxa whose abundance difference is significant (p-value is \<0.05) after adjusting for multiple comparisons.](nihms964261f3){#F3}

![Bacterial alpha-diversity (a) and phylogenetic relatedness differences (b) between infants with an earlier or later gestational age at birth\
(a) Bacterial alpha-diversity differences in infants with an earlier gestational age at birth (\<32 weeks GA, i.e. Earlier GA) and a later gestational age at birth (≥ 32 weeks, i.e. Later GA). P-value is adjusted for exposures and age (day of life). (b) Principal Coordinates Analysis plot showing bacterial phylogenetic relatedness differences between 6-week stool samples from infants with an earlier gestational age at birth (\<32 weeks GA, shown in red) and a later gestational age at birth (≥ 32 weeks, shown in blue). P-value is adjusted for exposures. PC1 = principal coordinate 1, PC2 = principal coordinate 2. Percentage refers to percentage of variance explained by the principal coordinate.](nihms964261f4){#F4}

![Bacterial alpha-diversity in premature infants across corrected gestational age at time of sample collection\
The bacterial alpha-diversity (SDI) of stool samples from premature indicated on the y-axis. A straight line was fitted to the bacterial alpha-diversity data, and indicates the change in stool bacterial alpha-diversity over corrected gestational age (slope) in premature infants. The p-value is adjusted for exposures, and represents the independent effect of corrected gestational age on bacterial alpha-diversity. On the x-axis is the corrected gestational age (gestational age at birth + day of life) at which a stool sample was collected.](nihms964261f5){#F5}

###### Subject cohort demographics

Number of subjects in each cohort and number of stool samples collected. Premature infants are infants born at a gestational age of less than 37 weeks. Gestational age (GA) at birth for all cohorts combined ranged from 24--43 weeks.

                        \# of Subjects   \# of Samples   GA Range
  --------------------- ---------------- --------------- --------------
  Preterm/NICU Cohort   17               65              24--32 weeks
  NHBCS - Preterm       13               13              29--36 weeks
  NHBCS - Term          176              189             37--43 weeks

###### Distribution of exposures in groups of infants based on gestational maturity

Extremely preterm infants are infants born at a gestational age (GA) of less than 28 weeks. Very preterm infants are infants born at a gestational age of greater than or equal to 28 weeks but less than 32 weeks, though we did not have any infants born at 28 weeks. Moderate-late preterm infants are born at a gestational age of 32 weeks or greater but less than 37 weeks. Term infants are born at 37 weeks or greater. Newborn antibiotics are antibiotics given to the infants in the first few days of life. Delivery mode was either a C-section (Caesarean section) or a vaginal delivery. Current breastmilk exposure is defined as subject was still consuming breastmilk at time of sample collection. Information on newborn antibiotic or breastmilk exposure was not always available, and thus the number of subjects or samples with this data available was noted in the table.

                                        Extremely Preterm (GA 24--27 weeks, 11 infants)   Very Preterm (GA 29--31 weeks, 5 infants)   Moderate-Late Preterm (32--36 weeks, 14 infants)   Term Infants (37--43 weeks, 176 infants)
  ------------------------------------- ------------------------------------------------- ------------------------------------------- -------------------------------------------------- ------------------------------------------
  Newborn Antibiotic Exposure           11/11 subjects (100%)                             4/4 (100%)                                  4/13 (29%)                                         4/172 (2%)
  Delivery Mode (\# C-sections/total)   7/11 subjects (64%)                               5/5 (100%)                                  6/14 (43%)                                         52/176 (30%)
  Current Breastmilk Exposure           41/43 samples (95%)                               16/16 (100%)                                15/17 (88%)                                        165/177 (93%)

###### NICU Premature Infant Cohort Exposures

Newborn antibiotics are antibiotics given to the infants in the first few days of life. A stool sample was considered to have antibiotic exposure if antibiotics were administered on same day as sample collection. Delivery mode was either a C-section (Caesarean section) or a vaginal delivery. Breastmilk exposure at time of sample collection was if the child was receiving breastmilk at time of stool collection. A stool sample was considered to belong to an infant who was exclusively fed breastmilk if no milk fortifier or formula was given before or on day of stool sample collection.

  Exposure                                                    Frequency
  ----------------------------------------------------------- ----------------------
  Newborn Antibiotic Exposure                                 16/17 subjects (94%)
  Antibiotic Exposure on Day of Sample Collection             14/65 samples (22%)
  Delivery Mode (\# C-sections/total)                         13/17 subjects (76%)
  Breastmilk Exposure at Time of Sample Collection            61/65 samples (94%)
  Exclusive Breastmilk Feeding at Time of Sample Collection   15/65 samples (23%)
